By Scientia Professor Gregory John Dore

Journal articles

Masters J; Goodman-Meza D; Russell D; Marks L; McCreary E; Jacka B; Seear K; Davis JS; Matthews G; Martinello M; Tong SYC; Dore GJ, 2025, 'Bacterial and fungal infections in persons who inject drugs.', Clin Microbiol Rev, pp. e0016223, http://dx.doi.org/10.1128/cmr.00162-23

Goodman-Meza D; Weiss RE; Poimboeuf ML; Feng J; Vijayan T; Martinello M; Matthews GV; Dore GJ, 2025, 'Comparative Effectiveness of Long-Acting Lipoglycopeptides vs Standard-of-Care Antibiotics in Serious Bacterial Infections', JAMA Network Open, 8, http://dx.doi.org/10.1001/jamanetworkopen.2025.11641

Sazzad HMS; Li H; Hajarizadeh B; Horsburgh BA; Grebely J; Dore GJ; Bull RA; Lloyd AR; Rodrigo C, 2025, 'Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics', Virus Research, 355, http://dx.doi.org/10.1016/j.virusres.2025.199566

Masters J; Jacka B; Barault M; Goodman-Meza D; Russell D; Matthews GV; Dore GJ; Valerio H; Martinello M, 2025, 'Incidence, Patient-Directed Discharge, Readmission, and Mortality Among People Hospitalized With Injecting-Related Infection: A Population-Based Linkage Study', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf257

Jacka BP; Cheng QL; Schiavone B; Darley DR; Kelleher AD; Dore GJ; Matthews GV, 2025, 'Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf142

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; George J; Matthews G; Grebely J; Pearson SA; Dore GJ, 2025, 'Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia', International Journal of Drug Policy, 139, http://dx.doi.org/10.1016/j.drugpo.2025.104790

Carson JM; Dore GJ, 2025, 'Learning From the Gaps: Rethinking Hepatitis C Virus Retreatment for People Who Inject Drugs.', Clin Infect Dis, http://dx.doi.org/10.1093/cid/ciaf083

Artenie A; Trickey A; Looker KJ; Stone J; Lim AG; Fraser H; Degenhardt L; Dore GJ; Grebely J; Cunningham EB; Hazarizadeh B; Low-Beer D; Luhmann N; Webb P; Hickman M; Vickerman P, 2025, 'Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis', Lancet Gastroenterology and Hepatology, 10, pp. 315 - 331, http://dx.doi.org/10.1016/S2468-1253(24)00442-4

Wheeler A; Masters J; Pradhan A; Roth JM; Degenhardt L; Dore GJ; Matthews GV; Cunningham EB; Peacock A; Colledge-Frisby S; Grebely J; Hajarizadeh B; Martinello M, 2025, 'Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf108

Stevens A; Lafferty L; Treloar C; Cunningham EB; Dore GJ; Grebely J; Marshall AD, 2025, 'Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection', International Journal of Drug Policy, 137, pp. 104720 - 104720, http://dx.doi.org/10.1016/j.drugpo.2025.104720

Dore GJ, 2025, 'Monitoring hepatitis C elimination among people who inject drugs: A broader approach is required', International Journal of Drug Policy, 137, http://dx.doi.org/10.1016/j.drugpo.2025.104712

Young C; Singh M; Jackson KJL; Field MA; Peters TJ; Angioletti-Uberti S; Frenkel D; Ravishankar S; Gupta M; Wang JJ; Agapiou D; Faulks ML; Al-Eryani G; Luciani F; Gordon TP; Reed JH; Danta M; Carr A; Kelleher AD; Dore GJ; Matthews G; Brink R; Bull RA; Suan D; Goodnow CC, 2025, 'A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease', Immunity, 58, pp. 412 - 430.e10, http://dx.doi.org/10.1016/j.immuni.2024.12.011

Hiebert-Suwondo L; Manning J; Tohme RA; Buti M; Kondili LA; Spearman CW; Prabdial-Sing N; Turnier V; Lazarus JV; Waked I; Ward JW; Miranda A; Sugiyama A; Hajarizadeh B; Varaldo C; Thomas C; Muñoz C; Leeman D; Dore G; Desalegn H; Aberra H; Cheinquer H; Qureshi H; Ivanchuk I; Grebely J; García-Samaniego J; Tanaka J; Tint KS; Poovorawan K; De Feo ME; Sonderup M; Aleksandrova M; Ali M; Hassany M; Marinho R; Hamid S; Punpetch S; Naing TS; Tanaka-Kumadai Y; Lim YS; Nartey Y, 2025, 'A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles', The Lancet Gastroenterology and Hepatology, http://dx.doi.org/10.1016/S2468-1253(25)00069-X

Byrne CD; Dore GJ, 2025, 'Metabolic dysfunction-associated steatotic liver disease a multisystem disease: Assessing the cost effectiveness of pharmacotherapies', Journal of Hepatology, http://dx.doi.org/10.1016/j.jhep.2025.02.001

Ivancovsky Wajcman D; Nicolàs A; Picchio CA; van Selm L; Dusheiko G; Younossi ZM; Dillon JF; Alqhatani SA; Razavi H; Colombo MG; Kautz A; Dore GJ; Lazarus JV, 2025, 'Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology', JHEP Reports, pp. 101436 - 101436, http://dx.doi.org/10.1016/j.jhepr.2025.101436

McKetin R; Degan TJ; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly PJ; Turner A; Clare PJ; Dean OM; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BTF; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Byrne M; Russell S; Zahra E; Berk M, 2024, 'A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial', Trials, 25, http://dx.doi.org/10.1186/s13063-024-08238-y

Martinello M; Carson JM; Post JJ; Finlayson R; Baker D; Read P; Shaw D; Bloch M; Doyle J; Hellard M; Filep E; Hosseini-Hooshyar S; Dore GJ; Matthews GV, 2024, 'Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae665

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8

Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B; Bah R; Li C; Byrne M; Butler T; Musarurwa B; Hooshmand E; Simpson A; Alrayyani M; Price N; Groom M, 2024, 'Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep study', Lancet Regional Health Western Pacific, 53, http://dx.doi.org/10.1016/j.lanwpc.2024.101240

MacLachlan JH; Allard N; Tran L; Savage A; Adamson E; Price V; Pearce C; Dore GJ; Cowie BC, 2024, 'Uptake of guideline-based testing for chronic viral hepatitis in Australian primary care: retrospective analysis of electronic medical record data', Australian Journal of Primary Health, 30, http://dx.doi.org/10.1071/PY24143

Marshall AD; Conway A; Cunningham EB; Valerio H; Silk D; Alavi M; Tillakeratne S; Wade A; Lam T; Zohrab K; Dunlop A; Connelly C; Cock V; Burns C; Henderson C; Christmass M; Dore GJ; Grebely J, 2024, 'A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study', Viruses, 16, http://dx.doi.org/10.3390/v16111763

Ryan H; Dore GJ; Grebely J; Byrne M; Cunningham EB; Martinello M; Lloyd AR; Hajarizadeh B, 2024, 'Hepatitis C treatment outcome among people in prison: The SToP-C study', Liver International, 44, pp. 2996 - 3007, http://dx.doi.org/10.1111/liv.16074

Tillakeratne S; Pearson SA; Alavi M; Hajarizadeh B; Martinello M; Law M; George J; Amin J; Matthews G; Grebely J; Dore GJ; Valerio H, 2024, 'Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia', Lancet Regional Health Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101185

Maher L; Wand H; Heard S; Starr M; Zolala F; Kemp R; Cunningham P; Drummer H; Hellard M; Kaldor J; Dore G, 2024, 'Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey.', Int J Drug Policy, pp. 104576, http://dx.doi.org/10.1016/j.drugpo.2024.104576

Maher L; Wand H; Heard S; Starr M; Zolala F; Kemp R; Cunningham P; Drummer H; Hellard M; Kaldor J; Dore G, 2024, 'Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey', International Journal of Drug Policy, 131, http://dx.doi.org/10.1016/j.drugpo.2024.104545

Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C, 2024, 'Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study', International Journal of Drug Policy, 129, http://dx.doi.org/10.1016/j.drugpo.2024.104477

Valerio H; Alavi M; Marshall AD; Hajarizadeh B; Amin J; Law M; Tillakeratne S; George J; Degenhardt L; Grebely J; Matthews GV; Dore GJ, 2024, 'Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study', Drug and Alcohol Review, 43, pp. 1080 - 1092, http://dx.doi.org/10.1111/dar.13688

Murdock NA; Alajaji NE; Schaefer R; Boone CA; Campo RE; Dore GJ; Gandhi M; Gorospe JR; Gulick RM; Hodder SL; Liu J; Rhee MS; Rooney JF; Vannappagari V; Wilkin T; Miller V, 2024, 'Long-acting HIV Treatments: Study Design, Logistics, and Access', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae337

Broady TR; Valerio H; Alavi M; Wheeler A; Silk D; Martinello M; Conway A; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Treloar C; Grebely J, 2024, 'Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104468

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Valerio H; Marshall AD; Conway A; Treloar C; Carter L; Martinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prain B; Alavi M; Dore GJ; Grebely J, 2024, 'Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104394

Farooq A; Valerio H; Wheeler A; Martinello M; Henderson C; Silk D; Degenhardt L; Read P; Dore GJ; Grebely J; Cunningham EB, 2024, 'Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study', Drug and Alcohol Review, 43, pp. 1019 - 1028, http://dx.doi.org/10.1111/dar.13828

Price O; Swanton R; Grebely J; Hajarizadeh B; Webb P; Peacock A; Dore GJ; Cowie BC; Vickerman P; Degenhardt L, 2024, 'Vaccination coverage among people who inject drugs: A systematic review', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104382

Price O; Dietze P; Maher L; Dore GJ; Sutherland R; Salom C; Bruno R; Crawford S; Degenhardt L; Larney S; Peacock A, 2024, 'High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs', Vaccine, 42, pp. 2877 - 2885, http://dx.doi.org/10.1016/j.vaccine.2024.03.051

Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J; Sargsyants N; Suleymanova L; Salkic N; Simonova M; Nemeth-Blazic T; Mravcik V; Kivimets K; Salupere R; Butsashvili M; Soselia G; Makara M; Tolmane I; Jancorienė L; Stratulat S; Flisiak R; Gheorghe L; Cernat R; Lakhov A; Stanevich O; Jarcuska P; Peck-Radosavljevic M; Robaeys G; Øvrehus A; Foster G; Sutinen J; Farkkila M; Rautiainen H; Vuoti S; Nikolova D; Pawlotsky JM; Rockstroh J; Sypsa V; Papatheodoridis G; Olafsson S; Feeney E; Teti E; Seguin-Devaux C; Pocock J; Reiff S; McDougall N; Van der Valk M; Dalgard O; Tato Marinho R; Dillon J; Peters E; Bojovic K; Matičič M; Kåberg M; Bruggmann P; Healy B; Chong VH; Yi S; Tucker J; Pasaribu LR; Tanaka J; Ashley EA; Abu Hassan MR; Mohammed NS; Chan HK; Gidaagaya S; Kyi KP; Hyung Joon K; Chin B; Baladjay PC; Kao JH; Wansom T; da Cruz B; Flower B; Ehsan E; Al Mahtab M; Khandu L; Bhadoria AS; Alavi M; KC P; Hamid S; Biryukov S; Alymbaeva D; Alaei A; Bakieva S; Flichman D, 2024, 'Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions', Lancet Gastroenterology and Hepatology, 9, pp. 366 - 382, http://dx.doi.org/10.1016/S2468-1253(23)00335-7

Yeoh YKJ; Dore GJ; Lockart I; Danta M; Flynn C; Blackmore C; Levy MT; George J; Alavi M; Hajarizadeh B, 2024, 'Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia', Internal Medicine Journal, 54, pp. 602 - 612, http://dx.doi.org/10.1111/imj.16252

Bin Usman Shah SH; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ, 2024, 'Corrigendum to “Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales” [JHEP Reports 4 (2022)] (JHEP Reports (2022) 4(10), (S2589555922001240), (10.1016/j.jhepr.2022.100552))', Jhep Reports, 6, http://dx.doi.org/10.1016/j.jhepr.2024.101022

Cheng Q; Valerio H; Cunningham EB; Shih STF; Silk D; Conway A; Treloar C; Murray C; Henderson C; Amin J; Read P; Dore GJ; Grebely J; Bath N; Milat A; Dunlop A; Holden J; Leadbeatter K; Day E; Habraken N; Dawson O; Degenhardt L; Scott C; Tillakeratne S; Marks P; Jayasinghe I; Martinez M; Reid H; Gleeson V; Van Dyk J; Mercade GE; Marshall AD; Obeid S; Wheeler A; Hooshyar SH; Catlett B; Verich A; Erratt A; Wheeler A; Ezard N; Reid D; Gorton C; Hayllar J; Lam T; Datta P; Wade A; Spruce S; Cock V; Cornwell M; Zohrab K; Christmass M; Connelly C; Cooper A; Montebello M; Cherry R; Dyer J; Arawal S; Press E; Horasak N; Lewis R; Carthew A; Morris D; Donohue K; Griffiths K; Lana JD; Shin S; Graf C; Hampson A; Qian S; Brown D; Lautier A; Curran C; Burns C; Raidu R; Stolzenhein K; Brabender W; Somes K; Abram N; Turne R; Larter S; Goodberg F; Luksza J; Hall M; Hazelwood S; Ismay C; McClurg B; Mincham C; Barlow K; Hoskins A; Salisbury K; Markham J; Talmet J; Dunn S; Mitchell A; McKinnon A; Smyth F; Snell L; Laing E; Clark M; Dorigo J, 2024, 'Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study', Value in Health, 27, pp. 216 - 225, http://dx.doi.org/10.1016/j.jval.2023.10.013

Shih STF; Stone J; Martin NK; Hajarizadeh B; Cunningham EB; Kwon JA; McGrath C; Grant L; Grebely J; Dore GJ; Lloyd AR; Vickerman P; Chambers GM, 2024, 'Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination', Open Forum Infectious Diseases, 11, pp. ofad637, http://dx.doi.org/10.1093/ofid/ofad637

Chaganti J; Poudel G; Cysique LA; Dore GJ; Kelleher A; Matthews G; Darley D; Byrne A; Jakabek D; Zhang X; Lewis M; Jha N; Brew BJ, 2024, 'Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: potential biomarkers and a window into pathogenesis', Frontiers in Neurology, 15, http://dx.doi.org/10.3389/fneur.2024.1350848

Bah R; Sheehan Y; Li X; Price N; Butler T; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2024, 'Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2024.104401

Hajarizadeh B; Carson JM; Byrne M; Grebely J; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Lloyd AR; Dore GJ, 2024, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, 31, pp. 21 - 34, http://dx.doi.org/10.1111/jvh.13895

Grebely J; Matthews S; Causer LM; Feld JJ; Cunningham P; Dore GJ; Applegate TL, 2024, 'We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?', Expert Review of Molecular Diagnostics, 24, pp. 177 - 191, http://dx.doi.org/10.1080/14737159.2023.2292645

Shah SHBU; Valerio H; Hajarizadeh B; Matthews G; Alavi M; Dore GJ, 2023, 'Cascade of care among people with hepatitis B in New South Wales, Australia', Journal of Viral Hepatitis, 30, pp. 926 - 938, http://dx.doi.org/10.1111/jvh.13881

Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J, 2023, 'Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review', Lancet Global Health, 11, pp. e1885 - e1898, http://dx.doi.org/10.1016/S2214-109X(23)00461-8

Hobday S; Valerio H; Combo T; Monaghan R; Scott C; Silk D; Murray C; Read P; Henderson C; Degenhardt L; Treloar C; Dore GJ; Grebely J; Martinello M, 2023, 'Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study', Drug and Alcohol Review, 42, pp. 1617 - 1632, http://dx.doi.org/10.1111/dar.13723

Cheng Q; Bajis S; Cunningham E; Shih STF; Schulz M; Marshall AD; Martin NK; Miners A; Hajarizadeh B; Wiseman V; Dore GJ; Grebely J, 2023, 'Health-related quality of life among people who inject drugs in Australia', Quality of Life Research, 32, pp. 3195 - 3207, http://dx.doi.org/10.1007/s11136-023-03465-3

Alter HJ; Barnes E; Biondi MJ; Cox AL; Eberts JD; Feld JJ; Liang TJ; Morrison J; Rice CM; Shoukry NH; Thomas DL; Van Gennip J; Weijer C; Aghemo A; Akiyama M; Ali M; Bader R; Bailey JR; Balaban Y; Banerjee S; Bartenschlager R; Baumert TF; Berenguer M; Bhadoria AS; Bonanni P; Bonella AE; Bruggmann P; Bruneau J; Bull RA; Butsashvili M; Cahn P; Caplan AL; Chappell RY; Chisari F; Chung R; Cooke G; Cox AL; Dalgard O; Dao DY; Darzi A; Dieterich D; Dillon JF; Dore GJ; Doyle JS; Drummer HE; Durbin AP; Dusheiko G; Eyal N; Ferguson K; Flisiak R; Forns X; Foster GR; Foung S; Gal-Tanamy M; Gane E; Gehring AJ; George J; Ghany MG; Gilbert DT; Glaze K; Goodman KW; Grebely J; Hamid S; Haybron DM; Holton R; Ignarro LJ; Jackson T; Jamieson D; Jollimore J; Karaba A; Klein M; Lauer G; Law M; Lemon SM; Liang TJ; Liu L; Lohmann V; Mak LY; Marinho RT; Marsh AA; Miller L; Negro F; Nguyen BV; Page K; Paterson K; Pedrana A; Pietschmann T; Pinker S; Plotkin S; Ray SC; Reau N; Remak WM; Ridruejo E; Roberts RJ, 2023, 'Joint statement in support of hepatitis C human challenge studies', Lancet Gastroenterology and Hepatology, 8, pp. 967 - 969, http://dx.doi.org/10.1016/S2468-1253(23)00314-X

Martinello M; Bhagani S; Shaw D; Orkin C; Cooke G; Gane E; Iser D; Ustianowski A; Kulasegaram R; Stedman C; Tu E; Grebely J; Dore GJ; Nelson M; Matthews GV, 2023, 'Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study', Jhep Reports, 5, http://dx.doi.org/10.1016/j.jhepr.2023.100867

Razavi-Shearer DM; Gamkrelidze I; Pan CQ; Jia J; Berg T; Gray RT; Lim YS; Chen CJ; Ocama P; Desalegn H; Abbas Z; Abdallah AR; Aghemo A; Ahmadbekova S; Ahn SH; Aho I; Akarca US; Al Masri NM; Alalwan AM; Alavian SM; Al-Busafi SA; Aleman S; Alfaleh FZ; Alghamdi AS; Al-Hamoudi WK; Aljumah AA; Al-Naamani K; Al-Rifai A; AlSerkal YM; Altraif IH; Amarsanaa J; Anderson M; Andersson MI; Armstrong P; Asselah T; Athanasakis K; Baatarkhuu O; Ben-Ari Z; Bensalem A; Bessone F; Biondi MJ; Bizri ARN; Blach S; Braga WSM; Brandão-Mello CE; Brosgart CL; Brown KA; Brown RS; Bruggmann P; Brunetto MR; Buti M; Cabezas J; Casanovas T; Chae C; Chan HLY; Cheinquer H; Chen PJ; Cheng KJG; Cheon ME; Chien CH; Choudhuri G; Christensen PB; Chuang WL; Chulanov V; Cisneros Garza LE; Coffin CS; Contreras FA; Coppola N; Cornberg M; Cowie B; Cramp ME; Craxi A; Crespo J; Cui F; Cunningham CW; Dalgard O; De Knegt RJ; De Ledinghen V; Dore GJ; Drazilova S; Duberg AS; Egeonu S; Elbadri M; El-Kassas M; El-Sayed MH; Estes C; Etzion O; Farag E; Ferradini L; Ferreira PRA; Flisiak R; Forns X; Frankova S; Fung J; Gane EJ; Garcia V; Garcia-Samaniego J; Gemilyan M; Genov J; Gheorghe LS, 2023, 'Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study', Lancet Gastroenterology and Hepatology, 8, pp. 879 - 907, http://dx.doi.org/10.1016/S2468-1253(23)00197-8

Back to profile page